A randomized, placebo-controlled, double-blind parallel-group study to evaluate the ocular and systemic safety and tolerability of repeated doses of propiverine hydrochloride in patients with primary Open-angle-glaucoma

Trial Profile

A randomized, placebo-controlled, double-blind parallel-group study to evaluate the ocular and systemic safety and tolerability of repeated doses of propiverine hydrochloride in patients with primary Open-angle-glaucoma

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Jan 2017

At a glance

  • Drugs Propiverine (Primary)
  • Indications Open-angle glaucoma
  • Focus Adverse reactions
  • Sponsors Apogepha
  • Most Recent Events

    • 02 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top